Literature DB >> 21310884

Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension.

A Campo1, S C Mathai, J Le Pavec, A L Zaiman, L K Hummers, D Boyce, T Housten, N Lechtzin, H Chami, R E Girgis, P M Hassoun.   

Abstract

The aim of this study was to examine the causes and outcomes of hospitalisation in patients with pulmonary arterial hypertension (PAH). 205 consecutive hospitalisations occurring between 2000 and 2009 in 90 PAH patients were studied. The leading causes for hospitalisation were right heart failure (RHF; 56%), infection (16%) and bleeding disorders (8%). For patients with RHF, in-hospital mortality was 14% overall, 46% for patients receiving inotropes and 48% for those admitted to the intensive care unit. The predictors for in-hospital mortality were the presence of connective tissue disease (CTD) (OR 4.92), systolic blood pressure <100 mmHg (OR 4.32) and Na ≤ 136 mEq · L(-1) (OR 4.29). Mortality after discharge was 13, 26 and 35% at 3, 6 and 12 months, respectively. World Health Organization functional class prior to admission, renal dysfunction, Charlson comorbidity index, and the presence of CTD were all predictors of mortality after discharge. Hyponatraemia and low systolic blood pressure upon admission and underlying CTD are the main prognostic factors for in-hospital mortality in patients with PAH admitted for RHF. The short-term outcomes after discharge are poor and remarkably worse in patients with underlying CTD or renal impairment. Early recognition of these factors may guide decisions regarding more aggressive therapy, including consideration for lung transplantation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310884     DOI: 10.1183/09031936.00148310

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  45 in total

Review 1.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

2.  Trends in pediatric pulmonary hypertension-related hospitalizations in the United States from 2000-2009.

Authors:  David B Frank; Matthew A Crystal; David L S Morales; Ken Gerald; Brian D Hanna; George B Mallory; Joseph W Rossano
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

Review 3.  The right ventricle in scleroderma (2013 Grover Conference Series).

Authors:  Paul M Hassoun
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

Review 4.  Determinants of right ventricular afterload (2013 Grover Conference series).

Authors:  Ryan J Tedford
Journal:  Pulm Circ       Date:  2014-06       Impact factor: 3.017

Review 5.  The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

6.  What's new: the management of acute right ventricular decompensation of chronic pulmonary hypertension.

Authors:  Mohammad Dalabih; Franz Rischard; Jarrod M Mosier
Journal:  Intensive Care Med       Date:  2014-09-03       Impact factor: 17.440

7.  An official American Thoracic Society Statement: pulmonary hypertension phenotypes.

Authors:  Raed A Dweik; Sharon Rounds; Serpil C Erzurum; Stephen Archer; Karen Fagan; Paul M Hassoun; Nicholas S Hill; Marc Humbert; Steven M Kawut; Michael Krowka; Evangelos Michelakis; Nicholas W Morrell; Kurt Stenmark; Rubin M Tuder; John Newman
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

8.  Registry to evaluate early and long-term disease management in PAH (REVEAL).

Authors:  Balaji Pakshirajan; Ajit S Mullasari
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 9.  Severe pulmonary arterial hypertension: stratification of medical therapies, mechanical support, and lung transplantation.

Authors:  Sonja Darrell Bartolome; Fernando Torres
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 10.  A Standardized and Comprehensive Approach to the Management of Cardiogenic Shock.

Authors:  Behnam N Tehrani; Alexander G Truesdell; Mitchell A Psotka; Carolyn Rosner; Ramesh Singh; Shashank S Sinha; Abdulla A Damluji; Wayne B Batchelor
Journal:  JACC Heart Fail       Date:  2020-11       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.